title: Between new genetic discoveries and large randomized trials--neurological research in the era of systems medicine.
abstract: The 2012 Eibsee meeting on 'Cellular Mechanisms of Neurodegeneration' addressed the need to integrate research on classical neurodegenerative mechanisms with investigations that relate to the immunological, glial and vascular sequels that accompany and often propagate neuronal injury. We report on the central topics that were addressed and discuss future directions towards establishing 'systems neurology' as a new integrated research field.
authors.affiliation: Munich Cluster for Systems Neurology, Munich, Germany. thomas.misgeld@lrz.tum.de
authors.forename: Thomas
authors.initials: T
authors.lastname: Misgeld
authors.forename: Stefan F
authors.initials: SF
authors.lastname: Lichtenthaler
authors.forename: Martin
authors.initials: M
authors.lastname: Dichgans
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D000818:Animals; D006801:Humans; D019636:Neurodegenerative Diseases / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D016032:Randomized Controlled Trials as Topic; D049490:Systems Biology